In Vivo and Biosimilar Antibodies
Accelerate Discovery and Development with High-Performance In Vivo Antibodies and Research Grade Biosimilars
Biotherapeutic antibodies, a cornerstone of modern medicine, revolutionize treatment approaches for various diseases. However, their successful development and clinical use hinge on comprehensive analysis and monitoring at the analytical stages. Deeply understanding the structure, function, and potential immunogenicity of biotherapeutic antibodies is crucial for their safe and effective development.
At Krishgen, we understand the pivotal role of antibodies in driving cutting-edge research and advancing the development of innovative biotherapeutics. With a focus on quality, diversity, and technical support, we provide the essential tools to propel your research endeavours forward.
Our catalog of antibodies from various principal partner companies can support you in:
- Target Identification and Validation: Use our antibodies to identify and validate potential drug targets, accelerating the drug discovery process.
- Lead Optimization: Optimize lead compounds by assessing their interactions with target proteins using our antibodies.
- Disease Diagnosis: Develop diagnostic assays using our antibodies to detect biomarkers associated with specific diseases.
- Prognostic and Predictive Markers: Identify biomarkers that predict disease progression, response to treatment, or prognosis.
- Therapeutic Monitoring: Monitor therapeutic responses and disease progression by measuring biomarkers using our antibodies.
Key Benefits of Using Our Antibodies:
- High Quality and Performance: Our antibodies are rigorously tested and validated to ensure exceptional specificity, sensitivity, and reproducibility.
- Diverse Selection: Choose from a wide range of antibodies targeting various biotherapeutic modalities, including mAbs, polyclonal antibodies, and recombinant antibodies.
- Expert Support: Our team of scientists is available to provide guidance and recommendations based on your specific research needs.
- Competitive Pricing: Access high-quality antibodies at competitive prices.
Explore Therapeutic Targets & Antibodies from with Antibody Systems, USA
Antibody System, based in the US, is a prominent provider of high-quality antibodies and reagents for life science research. Their products are known for their high specificity, sensitivity, and reproducibility, making them essential tools for researchers in various fields such as immunology, oncology, and cell biology.
They offer:
- Primary and Secondary Antibodies (mAb, pAb and Recombinant)
- Research Biosimilars (monoclonal antibodies, bispecific antibodies)
- In Vivo Antibodies
- Antibodies Targeting Specific Proteins and Antigens (cell surface markers, growth factors, cytokines etc)
Discovering the Power of Biotherapeutics with Bio-Rad Antibodies
Bio-Rad Antibodies empowers researchers and clinicians with a diverse range of high-affinity, well-characterized antibodies specifically designed to address the multifaceted needs of biotherapeutic analysis.
Without high quality antibodies you can get stuck developing the method, have to continually requalify new lots, end up feeling insecure about the results, and frustrated about not making progress.
Bio-Rad offer over a hundred antibodies against marketed biologic drugs suitable for pharmacokinetic (PK) and anti-drug-antibody (ADA) assays, to support bioanalytical assays for preclinical research and clinical trials, and therapeutic drug monitoring, for innovator and biosimilar products.
Why use Bio-Rad monoclonal anti-idiotypic antibodies?
- Highly specific to drug idiotope or drug-target complex, results in a selective PK assay
- Fully human, ideal as a surrogate positive control or calibrator for an ADA assay
- Sequence defined, well characterized reagent for secure supply throughout the study
- Recombinant production with stringent quality control for batch to batch consistency
- Non-animal-derived antibodies, reduces the use of animals in science
In Vivo Antibodies and Research Biosimilars from IchorBio
Ichor Bio is a leading biotechnology company specializing in the development and production of high-quality monoclonal antibodies for in vivo use. Based in the United Kingdom, Ichor Bio has established a reputation for providing innovative and reliable solutions for researchers and scientists worldwide.
Ichor Bio offers –
- In Vivo Antibodies (low, ultra low endotoxin and recombinant)
- Research Grade Biosimilars
- Other Monoclonal and Recombinant Antibodies
Wide Range of Targets
Exceptional Quality and Consistency
Diverse Applications
Competitive Pricing
If you cannot find what you are looking for, Get in touch with our team to explore more.